Pseudoephedrine/Paracetamol
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Common Cold
Conditions
Common Cold, Headache, Nasal Congestion
Trial Timeline
Jan 1, 2007 → Mar 1, 2008
NCT ID
NCT00378144About Pseudoephedrine/Paracetamol
Pseudoephedrine/Paracetamol is a approved stage product being developed by Johnson & Johnson for Common Cold. The current trial status is completed. This product is registered under clinical trial identifier NCT00378144. Target conditions include Common Cold, Headache, Nasal Congestion.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00378144 | Approved | Completed |
Competing Products
20 competing products in Common Cold